Biosimilars 2018

Biosimilars 2018 focuses upon “Market Dynamics of Biosimilars: A Result of Payers and Prescriber Perspectives”.  This Biosimilars networking meet focuses on the trends which the biosimilar markets is heading on since its launch till the present date as a perspective of the payers and physisicians. It takes into its fold the critical developmental procedures, analyses, regulatory factors and also pharmacovigilance including post marketing surveillance and clinical studies. Innovation and compliance to regulatory guidelines are the most critical aspects towards biosimilars and follow on biologics development and successful launching to the market. Moreover, with the fast changing global scenario and complexities of Brexit, the biologics landscape is potent to experience an appreciable effect on the present pharma market. The market leaders are already running into a price competition with smaller players who are penetrating the market. Thus it is important to understand the current market space and the involved market complexities through a quality networking between the KOL from around the globe.